NeuroSense Therapeutics
NRSN
NRSN
9 hedge funds and large institutions have $694K invested in NeuroSense Therapeutics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$397K | |
| 2 | +$173K | |
| 3 | +$65K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$48K |
| 5 |
FIA
FNY Investment Advisers
New York
|
+$3K |
Top Sellers
| 1 | -$184K | |
| 2 | -$135K | |
| 3 | -$38K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$22.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.41K |